Documents & Downloads

mono-Pal-MTO

siRNA-delivered Nanoparticle

Mono-Pal-MTO is a lipid-based compound designed for the effective delivery of siRNA through nanoparticle formulation. This palm oil-derived lipid combines the anticancer drug mitoxantrone (MTO) with palmitoleic acid, enhancing its potential for targeted cancer therapies. When used in conjunction with di-Pal-MTO at a 1:1 molar ratio, mono-Pal-MTO significantly improves siRNA cellular uptake and exhibits enhanced anticancer activity, making it a valuable tool for research in gene silencing and cancer treatment applications.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1349197-89-2
Applications	siRNA-delivered Nanoparticle
Formula	C₃₈H₅₆N₄O₇
Molecular Weight	680.87
SMILES	CCCCCC/C=C\CCCCCCCC(OCCNCCNC1=C2C(C(C3=C(O)C=CC(O)=C3C2=O)=O)=C(C=C1)NCCNCCO)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.